Sionna Therapeutics, Inc.

SEC 4 · Filed

0001704336-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jan 2, 2026

Grant, award or other acquisition by Cloonan Michael

Security
Non-Qualified Stock Option (right to buy)
Code
A
Shares
436,100
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-01-02",
  "direction": "A",
  "exercise_price": "39.21",
  "expiration": "2036-01-01",
  "footnotes": {
    "F1": "The shares underlying this option vest in forty-eight equal monthly installments following January 2, 2026, subject to the Reporting Person\u0027s continued service on each such vesting date."
  },
  "owners": [
    {
      "cik": "0001704336",
      "name": "Cloonan Michael",
      "roles": [
        "director",
        "officer"
      ],
      "title": "President \u0026 CEO"
    }
  ],
  "ownership": "D",
  "post_shares": "436100",
  "price": "0.0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Non-Qualified Stock Option (right to buy)",
  "shares": "436100",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "436100"
}